Author:
Holm G,Kylberg-Hanssen K,Svensson L
Abstract
Abstract
Sodium dodecyl sulfate (SDS) was introduced as an esterase inhibitor in the determination of two extremely labile, ultrashort-acting beta-blockers-esmolol and flumolol--in whole blood. SDS was much more efficient than previously used agents in preventing hydrolysis. The assay comprises solvent extraction, perfluoroacylation, and capillary gas-chromatography with electron-capture detection. The limit of detection (the concentration at which the coefficient of variation is 10-15%) for the drugs is 5 nmol/L of whole blood.
Publisher
Oxford University Press (OUP)
Subject
Biochemistry (medical),Clinical Biochemistry
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Design of High-Payload Ascorbyl Palmitate Nanosuspensions for Enhanced Skin Delivery;Pharmaceutics;2024-01-25
2. Simultaneous determination of clevidipine and its primary metabolite in dog plasma by liquid chromatography–tandem mass spectrometry: Application to pharmacokinetic study;Journal of Pharmaceutical and Biomedical Analysis;2014-11
3. Heat stabilization of blood spot samples for determination of metabolically unstable drug compounds;Bioanalysis;2013-01
4. In vitrostability and metabolism of O2′, O3′, O5′-tri-acetyl-N6-(3-hydroxylaniline) adenosine in rat, dog and human plasma: Chemical hydrolysis and role of plasma esterases;Xenobiotica;2011-04-13
5. Absorption, Distribution, Metabolism, and Excretion of Ximelagatran, an Oral Direct Thrombin Inhibitor, in Rats, Dogs, and Humans;Drug Metabolism and Disposition;2003-03-01